Not getting enough of deeper stages of sleep raises the risk of brain deterioration associated with Alzheimer’s disease, a ...
The Hearty Soul on MSN19h
Ingredient hidden in your spice rack could reverse Alzheimer's diseaseA household herb, rosemary, contains a potent compound that may combat neurodegenerative diseases like Alzheimer's. A new ...
The rates of dementia and Alzheimer’s disease are expected to double between 2030 and 2060 due in part to an estimated 50% of patients not being diagnosed ...
The first evidence that removing amyloid plaques may delay Alzheimer’s symptoms has now been published. In The Lancet Neurology on March 19, scientists led by Randall Bateman at Washington University ...
The brain runs on energy. Every thought, memory, or emotion sparks countless signals between nerve cells. That communication ...
Albers and colleagues are interested in whether olfactory dysfunction — the sometimes-subtle loss of sense of smell — can ...
Key regulators are not recommending Lilly’s Kisunla be cleared for the European market. The company says it plans to appeal ...
European regulatory committee rejects Lilly's Alzheimer's disease treatment due to potential risks of brain bleeding and ...
The EMA has recommended refusing marketing authorization for donanemab, a monoclonal antibody against amyloid beta, in the ...
After failing to pass muster with England’s drug reimbursement watchdog earlier this month, Eli Lilly’s Alzheimer’s disease ...
The European Union’s CHMP said that the benefits of the drug, already approved in the U.S., do not outweigh the risk of ...
Eli Lilly's Kisunla was approved in the U.S. for Alzheimer's last year, but now advisers to the European Medicines Agency say ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback